D'ADDATO, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 8.967
AS - Asia 8.066
EU - Europa 7.795
SA - Sud America 667
Continente sconosciuto - Info sul continente non disponibili 473
AF - Africa 368
OC - Oceania 13
Totale 26.349
Nazione #
US - Stati Uniti d'America 8.806
IT - Italia 3.580
CN - Cina 2.234
SG - Singapore 2.154
VN - Vietnam 1.867
GB - Regno Unito 1.294
DE - Germania 662
SE - Svezia 531
HK - Hong Kong 483
BR - Brasile 462
FR - Francia 383
IN - India 355
RU - Federazione Russa 280
KR - Corea 267
UA - Ucraina 242
BD - Bangladesh 212
NL - Olanda 191
IE - Irlanda 179
JP - Giappone 148
ZA - Sudafrica 123
CI - Costa d'Avorio 101
EE - Estonia 95
TG - Togo 81
CA - Canada 78
AR - Argentina 76
FI - Finlandia 61
PL - Polonia 57
JO - Giordania 55
CH - Svizzera 45
MX - Messico 43
PE - Perù 41
IQ - Iraq 40
ES - Italia 35
ID - Indonesia 35
PH - Filippine 30
SA - Arabia Saudita 27
AT - Austria 26
BG - Bulgaria 25
TR - Turchia 25
TH - Thailandia 24
GR - Grecia 23
BE - Belgio 22
EC - Ecuador 22
SC - Seychelles 21
CL - Cile 16
PK - Pakistan 16
CO - Colombia 15
VE - Venezuela 14
PY - Paraguay 13
TW - Taiwan 13
AU - Australia 12
AL - Albania 10
DZ - Algeria 10
RO - Romania 10
UZ - Uzbekistan 10
JM - Giamaica 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
TN - Tunisia 8
IR - Iran 7
LB - Libano 7
NP - Nepal 7
RS - Serbia 7
IL - Israele 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
HR - Croazia 5
LU - Lussemburgo 5
EU - Europa 4
GT - Guatemala 4
KE - Kenya 4
LT - Lituania 4
LV - Lettonia 4
MA - Marocco 4
NG - Nigeria 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
EG - Egitto 3
HN - Honduras 3
PS - Palestinian Territory 3
BB - Barbados 2
CM - Camerun 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
QA - Qatar 2
SI - Slovenia 2
TJ - Tagikistan 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
DK - Danimarca 1
DM - Dominica 1
Totale 25.859
Città #
Singapore 1.477
Southend 1.127
Ashburn 649
Hefei 634
Fairfield 587
San Jose 535
Santa Clara 524
Hong Kong 458
Chandler 416
Dong Ket 399
Ho Chi Minh City 371
Bologna 338
Hanoi 297
Milan 291
Wilmington 271
Woodbridge 271
Houston 259
Seattle 258
Princeton 244
Beijing 241
Council Bluffs 239
Seoul 238
Cambridge 213
Rome 213
Boardman 177
Dublin 177
Ann Arbor 176
Lauterbourg 154
Los Angeles 153
Jacksonville 151
New York 134
Turin 127
Tokyo 125
Nanjing 118
Padova 115
Westminster 109
Abidjan 101
Dallas 96
Naples 86
Berlin 83
Buffalo 83
Lomé 81
São Paulo 74
Bremen 73
Haiphong 56
Saint Petersburg 56
Amman 53
Bengaluru 53
Medford 52
Shanghai 51
Jinan 50
San Diego 46
Helsinki 45
Shenyang 42
Verona 42
Palermo 41
Redondo Beach 41
Warsaw 41
Nanchang 39
Atlanta 38
Phoenix 38
San Francisco 38
Chicago 36
Lima 36
Florence 35
Hebei 35
The Dalles 34
Da Nang 33
Dearborn 33
Guangzhou 31
Parma 31
Bari 30
Frankfurt am Main 30
London 30
Changsha 29
Modena 29
Redwood City 28
Amsterdam 26
Mülheim 25
Des Moines 24
Sofia 24
Zhengzhou 23
Nuremberg 22
Redmond 22
Rimini 22
Bern 21
Hải Dương 21
Brooklyn 20
Catania 20
Denver 20
Genoa 20
Montreal 20
Norwalk 20
Chengdu 19
Falls Church 19
Biên Hòa 18
Can Tho 18
Hangzhou 18
Orem 18
Tianjin 18
Totale 14.723
Nome #
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report 1.755
Lo studio Brisighella: 40 anni di ricerca nella prevenzione delle malattie cardiovascolari. 1.269
Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus® and placebo 990
Is the 2020 Sampson equation the best formula for LDL-C estimation? 302
Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients. 2022 May 18;14(10):209 299
Subjective effects of a combined lipid-lowering nutraceutical or ezetimibe on well-being and sexual performance in patients with perceived worsening of erectile function during statin treatment: a randomised clinical trial 283
A meta-analysis of Italian and Estonian individuals shows an effect of common variants in HMGCR on blood apoB levels 279
Prevalent seasoning and cooking fats, arterial stiffness and lipid pattern in a rural population sample: data from the Brisighella Heart Study 223
Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial 217
Wath are the major risk factors for type II diabetes development in the historical cohort of the Brisighella heart study? A 16-years follow-up 211
Relationship between lipid phenotypes, overweight, lipid lowering drug response and KIF6 and HMG-CoA genotypes in a subset of the brisighella heart study population 210
Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study 210
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 209
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 208
Observation of possibly relations between trend of CPK levels and LDL cholesterol in patients with hypercholesterolemia and asymptomatic primary high level of creatinechinase under statin therapy 203
Relazione tra livelli sierici di acido urico e rigidità arteriosa in un campione di adulti-anziani: i dati del Brisighella Heart Study 194
Prevalenza e determinati clinico-laboratoristici della sindrome metabolica in un campione di soggetti in età geriatrica: il Brisighella Heart Study 193
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 192
1A.11: ASSOCIATION OF KIF6 AND HMGCR LOCI WITH CARDIOMETABOLIC PHENOTYPES AND RESPONSE TO STATIN THERAPY IN THE BRISIGHELLA COHORT 192
Epidemiologia della sindrome metabolica nel Brisighella heart study 190
Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: data from the Brisighella Heart Study 188
A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease 187
Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study. 186
Arterial stiffness, sugar-sweetened beverages and fruits intake in a rural population sample: Data from the brisighella heart study 183
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up 182
Effect of spontaneous changes in dietary components and lipoprotein(a) levels: Data from the Brisighella Heart Study 180
Prevalence of metabolic syndrome in working population: preliminary results fo a campaign of cardiovascular risk screening 179
High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects 179
Brisighella Heart Study: metabolic syndrome in a borderline area. 178
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up. 174
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 172
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study 168
Efficacia della supplementazione dietetice con fibre solubili nelle gestione del rischio delle malattie cardiovascolari di pazienti affetti da SM: un trial clinico randomizzato open label di un anno 167
Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study 166
METABOLIC SYNDROME IN EUROPEAN RURAL POPULATION-DATA FROM THE BRISGHELLA HEART STUDY (ITALY) AND ENAH STUDY (CROATIA) 165
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: A randomized, double-blind, placebo controlled study 165
Cardiovascular mortality and physical activity in a rural population: the Brisighella Study. 163
Farmaci ipocolesterolemizzanti. 162
Brisghella Heart Study (BHS): controllo dei valori pressori dal 1984 al 2004. 161
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 161
Association between not HDL cholesterol levels and hypertension in the Brisighella Hart Study. 160
2B02: SERUM URIC ACID LEVEL, BUT NOT RENAL FUNCTION OR ARTERIAL STIFFNESS, IS ASSOCIATED TO WORSE BLOOD PRESSURE CONTROL IN GENERAL PRACTICE: DATA FROM THE BRISIGHELLA HEART STUDY 159
Correction to: Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: A three-arm, double-blind, randomized clinical trial (Nutrition and Metabolism (2017) 14 (61) DOI: 10.1186/s12986-017-0214-2) 159
Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study 158
Iperlipoproteinemia familiare combinata: complicanze cardiovascolari e cerebrovascolari 156
Osservazioni clinico sperimentali su possibili relazioni tra andamento dei valori sierici di creatinina kinasi e colesterolo LDL in pazienti asintomatici con ipercoelsterolemia ed elevati livelli di CPK in corso di terapia con statine. 155
A dietary education program involving the general population balances the effects of menopause on cardiovascular risk factors and metabolic syndrome incidence: data from the Brisghella Heart Study 155
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor 155
L'attività fisica durante il tempo libero e la mortalità per malattie cardiovascolari: i dati del Brisighella Heart Study. 155
A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO ®) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study) 153
Brisghella Heart Study (BHS): hypertension and obesity. 152
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 147
Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: A three-arm, double-blind, randomized clinical trial 147
Short- and Long-Term Stroke Risk after Urgent Management of Transient Ischaemic Attack: The Bologna TIA Clinical Pathway 146
Effect of a dietary education program on plasma lipid level in a rural setting: the Brisighella Heart Study 146
Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study 145
Physical activity and cardiovascular disease mortality: the Brisighella heart study 143
Relazione tra pressione arteriosa, colesterolemia ed apolipoproteina B in un campione di popolazione di grandi dimensioni: il Brisighella Heaat Study. 143
Changes in levels of serum cholesterol and development of hypertension in the Brisighella Heart Study. 143
Severe hypercholesterolaemia in a paediatric patient with congenital analbuminaemia 142
From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study 141
Attività fisica e aterosclerosi: i dati di Brisghella 141
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 141
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study 141
Effect of Lactotripeptides (Isoleucine-Proline-Proline/Valine-Proline-Proline) on Blood Pressure and Arterial Stiffness Changes in Subjects with Suboptimal Blood Pressure Control and Metabolic Syndrome: A Double-Blind, Randomized, Crossover Clinical Trial 141
Healthy Eating beyond Whole Grains—Insight on Associations between Diet Quality and Arterial Stiffness in the Brisighella Heart Study Cohort 140
Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study. 140
Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population. 140
How important are triglycerides as risk factors? 137
LDL-oxidation, serum uric acid and pulse-wave velocity relationship in chronic kidney disease: Data from the Brisighella heart study cohort 137
SERUM URIC ACID CHANGE AND MODIFICATION OF BLOOD PRESSURE AND FASTING PLASMA GLUCOSE IN A PHARMACOLOGICALLY UNTREATED POPOLATION SAMPLE: DATA FROM THE BRISIGHELLA HEART STUDY 136
Anlysis of lipid lowering treatment in patients at high cardiovascular risk discharged from S.Orsola-Malpighi Hospital, Bologna. 136
Cardiovascular risk in patients with metabolic syndrome enrolled in the Brisighella Heart Study. 136
Serum uric acid and markers of low-density lipoprotein oxidation in nonsmoking healthy subjects: data from the Brisighella Heart Study. 134
EFFECT OF SPONTANEOUS CHANGES IN DIETARY COMPONENTS AND SERUM LIPOPROTEIN(A): DATA FROM THE BRISIGHELLA HEART STUDY 133
RELATIONSHIP BETWEEN SERUM URIC ACID AND METABOLIC SYNDROME IN THE BRISIGHELLA HEART STUDY COHORT 133
The Brisighella Heart Study: cardiovascular complications in subjects in subjects with metabolic syndrome. 133
Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic 133
Confronto di due algoritmi diagnostici nella strima della prevalenza della sindrome metabolica in soggetti in età geriatrica e nella popolazione gnerale: Il Brisighella Heart Study. 131
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study 131
null 131
LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort 130
Modification of the dietary habits in the Brisighella Heart Study 129
Laboratory and Instrumental Risk Factors Associated with a Sudden Cardiac Death Prone ECG Pattern in the General Population: Data from the Brisighella Heart Study 129
Main predictors of metabolic syndrome and type 2 diabetes development in the historical cohort of the Brisighella Heart Study: a 16 years follow-up. 128
The Effect of Dietary Supplementation with Plant Sterols on Total and LDL-Cholesterol in Plasma Is Affected by Adherence to Mediterranean Diet: Insights from the DESCO Randomized Clinical Study 127
Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting 126
Changes in levels of serum cholesterol and development of hypertension in the Brisighella Heart Study. 126
ADJUSTED NECK CIRCUMFERENCE AND METABOLIC SYNDROME: RESULTS FROM THE BRISIGHELLA HEART STUDY 125
Brisghella Heart Study (BHS): ipertensione ed obesità. 125
Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes (Cardiovascular Diabetology, (2022), 21, 1, (57), 10.1186/s12933-022-01495-8) 124
La compromissione della funzione renale in un campione di popolazione generale: dati del Brisighella Heart Study. 124
Relationship Between Serum Uric Acid and Electrocardiographic Alterations in a Large Sample of General Population: Data From the Brisighella Heart Study 124
CORRELATIONS BETWEEN SERUM THIOCYANATES AND HEART RISK FACTORS IN THE HISTORICAL BRISIGHELLA HEART STUDY COHORT 123
Plasma lipid effects of corn oil and extra-virgin olive oil in hypercholesterolemic subjects: a randomized, controlled trial. 123
Physical activity trend in a rural population submitted to a nutritional program: the Brisighella Heart Study 123
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 121
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 120
Association between cigarette smoking and serum lipid levels in a italian cohort: the Brisighella Heart Study. 120
Hypertension and metabolic syndrome in the Brisighella Heart Study 119
Totale 19.546
Categoria #
all - tutte 65.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.003 0 82 128 95 231 161 40 186 118 110 493 359
2022/20232.687 255 347 137 335 166 161 126 174 449 142 282 113
2023/20241.247 51 160 72 106 104 104 99 101 76 140 90 144
2024/20254.144 194 564 299 293 811 235 313 166 142 127 242 758
2025/20268.497 715 997 879 706 827 481 677 443 1.283 643 387 459
2026/20271.700 1.179 521 0 0 0 0 0 0 0 0 0 0
Totale 26.349